140 related articles for article (PubMed ID: 37819699)
1. An Updated Systematic Review and Meta-Analysis on the Technical, Oncologic, and Safety Outcomes of Microwave Ablation in Patients with Renal Cell Carcinoma.
Wu J; Sami S; Lajkosz K; Kishibe T; Ordon M
J Endourol; 2023 Dec; 37(12):1314-1330. PubMed ID: 37819699
[No Abstract] [Full Text] [Related]
2. Efficacy and Safety of Microwave Ablation for Malignant Renal Tumors: An Updated Systematic Review and Meta-Analysis of the Literature Since 2012.
Choi SH; Kim JW; Kim JH; Kim KW
Korean J Radiol; 2018; 19(5):938-949. PubMed ID: 30174484
[TBL] [Abstract][Full Text] [Related]
3. Microwave ablation of malignant renal tumours: intermediate-term results and usefulness of RENAL and mRENAL scores for predicting outcomes and complications.
Ierardi AM; Puliti A; Angileri SA; Petrillo M; Duka E; Floridi C; Lecchi M; Carrafiello G
Med Oncol; 2017 May; 34(5):97. PubMed ID: 28421553
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous microwave ablation of T1a and T1b renal cell carcinoma: short-term efficacy and complications with emphasis on tumor complexity and single session treatment.
Wells SA; Wheeler KM; Mithqal A; Patel MS; Brace CL; Schenkman NS
Abdom Radiol (NY); 2016 Jun; 41(6):1203-11. PubMed ID: 27167230
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous Microwave Ablation of Histologically Proven T1 Renal Cell Carcinoma.
Aarts BM; Prevoo W; Meier MAJ; Bex A; Beets-Tan RGH; Klompenhouwer EG; Gómez FM
Cardiovasc Intervent Radiol; 2020 Jul; 43(7):1025-1033. PubMed ID: 32052093
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous Microwave Ablation Versus Robot-Assisted Partial Nephrectomy for Stage I Renal Cell Carcinoma: A Propensity-Matched Cohort Study Focusing Upon Long-Term Follow-Up of Oncologic Outcomes.
Chlorogiannis DD; Kratiras Z; Efthymiou E; Moulavasilis N; Kelekis N; Chrisofos M; Stravodimos K; Filippiadis DK
Cardiovasc Intervent Radiol; 2024 May; 47(5):573-582. PubMed ID: 38561521
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of Microwave Ablation and Cryoablation for the Treatment of Renal Cell Carcinoma: A Systematic Literature Review and Meta-analysis.
McClure T; Lansing A; Ferko N; Wright G; Ghosh SK; Raza S; Kalsekar I; Clarke K; Talenfeld A
Urology; 2023 Oct; 180():1-8. PubMed ID: 37331485
[TBL] [Abstract][Full Text] [Related]
8. Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma.
Maciolek KA; Abel EJ; Posielski NM; Hinshaw JL; Lubner MG; Lee FT; Ziemlewicz TJ; Wells SA
Eur Radiol; 2019 Nov; 29(11):6319-6329. PubMed ID: 31016448
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of RFA versus MWA for T1a renal cell carcinoma: a propensity score analysis.
Aarts BM; Gomez FM; Lopez-Yurda M; Bevers RFM; Herndriks J; Beets-Tan RGH; Bex A; Klompenhouwer EG; van der Meer RW
Eur Radiol; 2023 Feb; 33(2):1040-1049. PubMed ID: 36066733
[TBL] [Abstract][Full Text] [Related]
10. US-guided percutaneous microwave ablation versus open radical nephrectomy for small renal cell carcinoma: intermediate-term results.
Yu J; Liang P; Yu XL; Cheng ZG; Han ZY; Zhang X; Dong J; Mu MJ; Li X; Wang XH
Radiology; 2014 Mar; 270(3):880-7. PubMed ID: 24475805
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous microwave ablation therapy of renal cancer local relapse after radical nephrectomy: a feasibility and efficacy study.
Ierardi AM; Carnevale A; Rossi UG; Renzulli M; Garanzini E; Golfieri R; Macchione N; Cittanti C; Giganti M; Carrafiello G
Med Oncol; 2020 Mar; 37(4):27. PubMed ID: 32166412
[TBL] [Abstract][Full Text] [Related]
12. A multicenter 10-year oncologic outcome of ultrasound-guided percutaneous microwave ablation of clinical T1 renal cell carcinoma: will it stand the test of time?
Yu J; Wang H; Cheng ZG; Liu FY; Li QY; He GZ; Luo YC; Yu XL; Han ZY; Liang P
Eur Radiol; 2022 Jan; 32(1):89-100. PubMed ID: 34195888
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous Microwave Ablation of Stage T1b Renal Cell Carcinoma: Short-Term Assessment of Technical Feasibility, Short-Term Oncologic Outcomes, and Safety.
Guo J; Arellano RS
J Endourol; 2020 Oct; 34(10):1021-1027. PubMed ID: 32498630
[No Abstract] [Full Text] [Related]
14. Long-Term Clinical Outcomes Following Radiofrequency and Microwave Ablation of Renal Cell Carcinoma at a Single VA Medical Center.
Abboud SE; Patel T; Soriano S; Giesler J; Alvarado N; Kang P
Curr Probl Diagn Radiol; 2018; 47(2):98-102. PubMed ID: 28648469
[TBL] [Abstract][Full Text] [Related]
15. Complication Rates and Risk of Recurrence After Percutaneous Radiofrequency Ablation and Microwave Ablation for the Treatment of Liver Tumors: a Meta-analysis.
Alhasan AS; Daqqaq TS; Alhasan MS; Ghunaim HA; Aboualkheir M
Acad Radiol; 2024 Apr; 31(4):1288-1301. PubMed ID: 38087720
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous microwave ablation of renal masses in a UK cohort.
John JB; Anderson M; Dutton T; Stott M; Crundwell M; Llewelyn R; Gemmell A; Bufacchi R; Spiers A; Campain N
BJU Int; 2021 Apr; 127(4):486-494. PubMed ID: 32871034
[TBL] [Abstract][Full Text] [Related]
17. Microwave ablation of cT1a renal cell carcinoma: oncologic and functional outcomes at a single center.
Wilcox Vanden Berg RN; Calderon LP; LaRussa S; Enobakhare O; Craig K; Del Pizzo J; McClure TD
Clin Imaging; 2021 Aug; 76():199-204. PubMed ID: 33964597
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of Advanced Age in Patients with T1a Renal Cell Carcinoma Treated by Microwave Ablation: A 16-Year Experience.
Hou Q; Wang Y; Zhang D; Luo Y; Dong L; Mu M; Yu J; Liang P
Technol Cancer Res Treat; 2023; 22():15330338231183585. PubMed ID: 38018134
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous Microwave Ablation versus Laparoscopic Partial Nephrectomy for cT1a Renal Cell Carcinoma: A Propensity-matched Cohort Study of 1955 Patients.
Yu J; Zhang X; Liu H; Zhang R; Yu X; Cheng Z; Han Z; Liu F; Hao G; Mu MJ; Liang P
Radiology; 2020 Mar; 294(3):698-706. PubMed ID: 31961239
[TBL] [Abstract][Full Text] [Related]
20. Development of a Risk-stratified Approach for Follow-up Imaging After Percutaneous Thermal Ablation of Sporadic Stage One Renal Cell Carcinoma.
Dreyfuss LD; Wells SA; Best SL; Hedican SP; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Nakada SY; Abel EJ
Urology; 2019 Dec; 134():148-153. PubMed ID: 31465794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
